NewGenIvf Group (NASDAQ:NIVF) Major Shareholder Sells $68,253.60 in Stock

NewGenIvf Group Limited (NASDAQ:NIVF) major shareholder Financial Lp Hrt sold 85,317 shares of NewGenIvf Group stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $0.80, for a total transaction of $68,253.60. Following the transaction, the insider directly owned 54,561 shares of the company’s stock, valued at approximately $43,648.80. This represents a 60.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Tuesday, May 26th, Financial Lp Hrt purchased 27,993 shares of NewGenIvf Group stock. The shares were purchased at an average cost of $0.92 per share, with a total value of $25,753.56.
• On Friday, May 22nd, Financial Lp Hrt purchased 137,541 shares of NewGenIvf Group stock. The shares were purchased at an average cost of $0.99 per share, with a total value of $136,165.59.

NewGenIvf Group Stock Up 14.6%

Shares of NIVF stock traded up $0.12 during trading hours on Thursday, reaching $0.97. 3,389,162 shares of the stock were exchanged, compared to its average volume of 1,436,935. NewGenIvf Group Limited has a 12-month low of $0.72 and a 12-month high of $1,839.00. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98. The company’s 50-day moving average price is $1.68 and its 200-day moving average price is $6.93.

NewGenIvf Group (NASDAQ:NIVF) last released its quarterly earnings results on Tuesday, March 31st. The company reported ($287.24) EPS for the quarter. The company had revenue of $1.42 million for the quarter. Analysts expect that NewGenIvf Group Limited will post 4.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.